BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Frew JW, Hawkes JE, Krueger JG. Topical, systemic and biologic therapies in hidradenitis suppurativa: pathogenic insights by examining therapeutic mechanisms. Ther Adv Chronic Dis 2019;10:2040622319830646. [PMID: 30854183 DOI: 10.1177/2040622319830646] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 14.0] [Reference Citation Analysis]
Number Citing Articles
1 Muddasani S, Flood KS, Fleischer AB. An assessment of current practices in the treatment of hidradenitis suppurativa: the rise of biologic therapy. Journal of Dermatological Treatment. [DOI: 10.1080/09546634.2020.1825613] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 de Oliveira RTG, Agostinho GLPL, Granja R, Oyafuso LKM, Criado PR. Socioeconomic impact of high-cost drugs in Brazilian dermatology. Legal and financial aspects, and impact on clinical practice. An Bras Dermatol 2021;96:200-9. [PMID: 33573869 DOI: 10.1016/j.abd.2020.08.010] [Reference Citation Analysis]
3 Colosimo C, Yon JR, Fredericks C, Kingsley S, Gupta S, Mentzer CJ, Bokhari F, Poulakidas S. Obesity is Not Associated With Need for Skin Grafting After Hidradenitis Excision. Am Surg 2021;87:458-62. [PMID: 33047967 DOI: 10.1177/0003134820950686] [Reference Citation Analysis]
4 Navrazhina K, Garcet S, Zheng X, Hur HB, Frew JW, Krueger JG. High inflammation in hidradenitis suppurativa extends to perilesional skin and can be subdivided by lipocalin-2 expression. J Allergy Clin Immunol 2021:S0091-6749(21)00832-0. [PMID: 34081946 DOI: 10.1016/j.jaci.2021.05.027] [Reference Citation Analysis]
5 Wong YL, Pandey M, Choudhury H, Lim WM, Bhattamisra SK, Gorain B. Development of In-Situ Spray for Local Delivery of Antibacterial Drug for Hidradenitis Suppurativa: Investigation of Alternative Formulation. Polymers (Basel) 2021;13:2770. [PMID: 34451309 DOI: 10.3390/polym13162770] [Reference Citation Analysis]
6 Pereira MN, Tolentino S, Pires FQ, Anjos JL, Alonso A, Gratieri T, Cunha-filho M, Gelfuso GM. Nanostructured lipid carriers for hair follicle-targeted delivery of clindamycin and rifampicin to hidradenitis suppurativa treatment. Colloids and Surfaces B: Biointerfaces 2021;197:111448. [DOI: 10.1016/j.colsurfb.2020.111448] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
7 Navrazhina K, Frew JW. Consensus definitions of disease activity in hidradenitis suppurativa: crossing the semantic gap. Br J Dermatol 2020;182:7. [PMID: 31583685 DOI: 10.1111/bjd.18468] [Reference Citation Analysis]
8 Mintoff D, Borg I, Pace NP. The Clinical Relevance of the Microbiome in Hidradenitis Suppurativa: A Systematic Review. Vaccines (Basel) 2021;9:1076. [PMID: 34696185 DOI: 10.3390/vaccines9101076] [Reference Citation Analysis]
9 Johnston DGW, Kirby B, Tobin DJ. Hidradenitis suppurativa: A folliculotropic disease of innate immune barrier dysfunction? Exp Dermatol 2021;30:1554-68. [PMID: 34418166 DOI: 10.1111/exd.14451] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Del Duca E, Morelli P, Bennardo L, Di Raimondo C, Nisticò SP. Cytokine Pathways and Investigational Target Therapies in Hidradenitis Suppurativa. Int J Mol Sci 2020;21:E8436. [PMID: 33182701 DOI: 10.3390/ijms21228436] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
11 Cohen JM, Kridin K, Perez-Chada LM, Merola JF, Cohen AD. Hepatitis B and C among patients with hidradenitis suppurativa: a population-based study. Int J Dermatol 2021. [PMID: 33998670 DOI: 10.1111/ijd.15578] [Reference Citation Analysis]
12 Marasca C, Tranchini P, Marino V, Annunziata MC, Napolitano M, Fattore D, Fabbrocini G. The pharmacology of antibiotic therapy in hidradenitis suppurativa. Expert Review of Clinical Pharmacology 2020;13:521-30. [DOI: 10.1080/17512433.2020.1762571] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
13 Rosales Santillan M, Morss PC, Porter ML, Kimball AB. Biologic therapies for the treatment of hidradenitis suppurativa. Expert Opin Biol Ther 2020;20:621-33. [PMID: 32077334 DOI: 10.1080/14712598.2020.1732918] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
14 Choi E, Ooi XT, Chandran NS. Hidradenitis suppurativa in pediatric patients. J Am Acad Dermatol 2020:S0190-9622(20)32436-1. [PMID: 32822788 DOI: 10.1016/j.jaad.2020.08.045] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
15 Williams SC, Frew JW, Krueger JG. A systematic review and critical appraisal of metagenomic and culture studies in hidradenitis suppurativa. Exp Dermatol 2021;30:1388-97. [PMID: 32614993 DOI: 10.1111/exd.14141] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
16 Frew JW, Marzano AV, Wolk K, Join-lambert O, Alavi A, Lowes MA, Piguet V. A Systematic Review of Promising Therapeutic Targets in Hidradenitis Suppurativa: A Critical Evaluation of Mechanistic and Clinical Relevance. Journal of Investigative Dermatology 2021;141:316-324.e2. [DOI: 10.1016/j.jid.2020.06.019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
17 Collier EK, Seivright JR, Shi VY, Hsiao JL. Pregnancy and breastfeeding in hidradenitis suppurativa: A review of medication safety. Dermatol Ther 2021;34:e14674. [PMID: 33320387 DOI: 10.1111/dth.14674] [Reference Citation Analysis]
18 Narla S, Lyons AB, Hamzavi IH. The most recent advances in understanding and managing hidradenitis suppurativa. F1000Res 2020;9:F1000 Faculty Rev-1049. [PMID: 32884675 DOI: 10.12688/f1000research.26083.1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
19 Jørgensen AR, Yao Y, Thomsen SF, Ring HC. Treatment of hidradenitis suppurativa with tetracycline, doxycycline, or lymecycline: a prospective study. Int J Dermatol 2021;60:785-91. [PMID: 33660281 DOI: 10.1111/ijd.15459] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Coskun BN, Yagiz B, Pehlivan Y, Dalkilic E. Isotretinoin-induced sacroiliitis in patients with hidradenitis suppurativa: a case-based review. Rheumatol Int 2019;39:2159-65. [DOI: 10.1007/s00296-019-04434-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]